Introduction
The transmission of viral hepatitis such as hepatitis type B' is the most serious complication of the use of blood products. The Australia or hepatitis B surface antigen (HBsAg) is a specific marker of infection with the agent of viral hepatitis B, and donors with HBs antigenaemia should be excluded. A World Health Organization report has called for a simple, rapid, sensitive, and specific method for detecting HBsAg in blood donors,2 and recommended as a desired minimum a method with the sensitivity of counterimmunoelectrophoresis (C.I.E.P.). A screening test's sensitivity, its standard of performance, and the specificity of the reagents obviously influence the rate of detection of HBsAg in donors, but the W.H.O. report maintains that most apparently healthy carriers have a high titre of HBsAg which is easily detected by relatively insensitive methods such as C.I.E.P.
We reviewed our four years' experience of screening all donations for HBsAg with C.I.E.P. and compared C.I.E.P. with two other screening tests-reverse passive haemagglutination (R.P.H.A.) and radioimmunoassay (R.I.A.).
Donors and Methods
Over four years 438 937 donations were screened for HBsAg by C.I.E.P.,3 165 811 of them for the first time. Any donor confirmed to be positive for HBsAg is advised not to donate again so 273 126 donations were from people who had already been found to be negative for HBsAg.
All donations found to be negative for HBsAg by C.I.E.P. were available for issue to hospitals, but some serum from each donor was preserved frozen for one year for subsequent investigation. Later 27 487 of these preserved sera were tested for HIBsAg by R. 
Results

FOUR-YEAR REVIEW
Of the 165 811 donors tested for the first time 207 (0-12%) had HBs antigenaemia. Ten donors, apparently negative at the first test, were found to be positive for HB3sAg at the next donation. The preserved sera from these 10 donors were retested by C.I.E.P., and the neat sera gave either a definite negative or an extremely doubtful positive reaction. After concentration or dilution they were retested, and nine were shown to contain HBsAg; four of these sera were of high titre and five of low titre. The 10th serum still gave negative reactions on C.I.E.P. These 10 sera were then tested by R.P.H.A. and by R.I.A. The serum which was consistently negative on C.I.E.P. remained negative, but the other nine sera gave clear and specific positive reactions for HBsAg. We confirmed that four sera contained a high titre and five a low titre of HBsAg, which indicated that C. Summary Plasma nicotine three minutes after smoking a cigarette was measured in 10 sedentary workers in mid-morning and five hours later on four typical working days. The average mid-morning level after they had been smoking their usual cigarettes (mean nicotine yield 134 mg) was 150 4 nmol/l (24 4 ng/ml) (range 956-236-7 nmol/l (155-384 ng/ml)). Despite great variation between smokers the mid-morning levels of each smoker were fairly consistent over the four mornings and correlated 0 82 with their carboxyhaemoglobin levels. After continuing to smoke their usual brand or switching to a high-nicotine brand (3 2 mg) average afternoon levels of 185 6 and 180 0 nmol/l (30-1 and 29 2 ng/ml) respectively were not significantly higher than the morning levels, but after switching to low-nicotine cigarettes (0-14 mg) the plasma nicotine dropped to an average of 52-4 nmol/l (8 5 ng/ml). The changes between morning and afternoon while smoking usual or high-nicotine cigarettes showed marked individual variation. The findings suggest that the plasma nicotine level just after a cigarette depends more on the way the cigarette is smoked than on its nicotine yield or the number which have been smoked over the preceding few hours.
Introduction
Official tables listing the tar and nicotine yields of cigarettes are based on the rigidly standardized and unvaried puffing of smoking machines. This is entirely appropriate for the comparison of cigarette brands but has trapped many into assuming too directly the implications for less hazardous smoking. Almost universally the public are recommended that, in the interest of their health, if they cannot stop smoking cigarettes they should try to switch to the low-tar, low-nicotine brands.
But people are not smoking machines. Even though some smokers may take a 35-ml, two-second puff once a minute to a butt length of 20 mm or the tip overwrap plus 3 mm, which- ever is the greater, there is no guarantee that they will smoke a cigarette in the same way irrespective of its nicotine yield. Indeed, the evidence is to the contrary. Smokers tend to respond to changes in the tar and nicotine yields of cigarettes by altering their smoking pattern to regulate the nicotine intake.'13 When the nicotine yield is high they tend to smoke less, and when it is low they compensate by smoking more. Since tar and nicotine yields of currently available cigarettes correlate so highly (r=0-96) it has still to be proved that the adjustment relates to nicotine and not to tar or some other covarying component.
Apart from the number of cigarettes smoked there are more subtle ways in which a smoker may consciously or unconsciously alter his nicotine intake. Puff-size, puff-velocity, puff-rate, number of puffs per cigarette, proximity of puffs to tip, proportion of puff inhaled, and depth and duration of inhalation are some of the more obvious factors. Hitherto, the most sophisticated measure of nicotine intake has been by the analysis of nicotine in cigarette butts,3 4 which makes use of the close linear relation between the amount of nicotine deposited in the filter and the amount which-passes through it. But even this tells us only how much the smoker has taken into his mouth.
For quantitative study the measurement of nicotine in urine is limited by the pH dependence of its excretion, and for various reasons it has been difficult to measure in blood. A reliable blood method has now been developed,5 and we have investigated the plasma nicotine levels in different smokers and the degree to which an individual smoker shows a consistent level on different days, at different times of the day, and when smoking cigarettes with different nicotine yields.
Subjects and Methods
Ten clerical and social workers volunteered to take part in the study. They were all regular cigarette smokers who said that they inhaled deeply. Venous blood samples were taken between 10 a.m. and 11.30 a.m. and again about five hours later (3 p.m. to 4.30 p.m.) on four typical working days: two days of one week (days 1 and 2) and the same two days of the following week (days 3 and 4). For each subject the blood was taken at the same time on all four days. To avoid variations due to different time-spans between the last cigarette and collection of the samples the volunteers smoked a cigarette immediately before each sample, which was then taken three minutes after completion of the cigarette. On the morning of each day of study the subjects smoked their usual brand in the usual way. For the five hours between sampling they were given a liberal supply of cigarettes with instructions to smoke as much or as little as they wanted but not to offer or accept cigarettes from other people. On days 1 and 3 they were given their usual brand, but on days 2 and 4 they were given a high-or low-nicotine cigarette according to a balanced crossover design.
The high nicotine cigarette used was Capstan Full Strength (tar 38 mg, nicotine 3-2 mg) and the low nicotine cigarette Silk Cut
